NO315786B1 - Inhibisjon av leukotrienbiosyntese med ureaderivater - Google Patents
Inhibisjon av leukotrienbiosyntese med ureaderivater Download PDFInfo
- Publication number
- NO315786B1 NO315786B1 NO19970477A NO970477A NO315786B1 NO 315786 B1 NO315786 B1 NO 315786B1 NO 19970477 A NO19970477 A NO 19970477A NO 970477 A NO970477 A NO 970477A NO 315786 B1 NO315786 B1 NO 315786B1
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- urea
- phenyl
- carbon atoms
- phenylurea
- Prior art date
Links
- 150000002617 leukotrienes Chemical class 0.000 title claims abstract description 21
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 17
- 230000005764 inhibitory process Effects 0.000 title claims description 23
- 150000003672 ureas Chemical class 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 97
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 59
- 125000004432 carbon atom Chemical group C* 0.000 claims description 53
- -1 3-(4-butylphenyl)-1-hydroxy-1 - phenylurea Chemical compound 0.000 claims description 40
- 239000004202 carbamide Substances 0.000 claims description 32
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 27
- 125000000217 alkyl group Chemical group 0.000 claims description 23
- 239000001257 hydrogen Substances 0.000 claims description 20
- 229910052739 hydrogen Inorganic materials 0.000 claims description 20
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000001424 substituent group Chemical group 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 150000001768 cations Chemical class 0.000 claims description 9
- 125000004414 alkyl thio group Chemical group 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- JGSIAOZAXBWRFO-UHFFFAOYSA-N 3-methylsulfanyl-1-phenyl-4,5-dihydrobenzo[g]indazole Chemical compound C1CC2=CC=CC=C2C2=C1C(SC)=NN2C1=CC=CC=C1 JGSIAOZAXBWRFO-UHFFFAOYSA-N 0.000 claims description 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical group 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- 238000001727 in vivo Methods 0.000 claims description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 claims description 4
- XUPPUXBZXIIYGF-UHFFFAOYSA-N 1-butan-2-yl-1-hydroxy-3-phenylurea Chemical compound CCC(C)N(O)C(=O)NC1=CC=CC=C1 XUPPUXBZXIIYGF-UHFFFAOYSA-N 0.000 claims description 4
- VHDKOUQVFHQSLW-UHFFFAOYSA-N 1-heptan-4-yl-1-hydroxy-3-phenylurea Chemical compound CCCC(CCC)N(O)C(=O)NC1=CC=CC=C1 VHDKOUQVFHQSLW-UHFFFAOYSA-N 0.000 claims description 4
- FTHPVFHMPAFSEK-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-(4-phenoxyphenyl)urea Chemical compound C1=CC(NC(=O)N(O)C)=CC=C1OC1=CC=CC=C1 FTHPVFHMPAFSEK-UHFFFAOYSA-N 0.000 claims description 4
- DNKZRQIPYKONDX-UHFFFAOYSA-N 1-hydroxy-1-pentan-3-yl-3-(2-phenoxyphenyl)urea Chemical compound CCC(CC)N(O)C(=O)NC1=CC=CC=C1OC1=CC=CC=C1 DNKZRQIPYKONDX-UHFFFAOYSA-N 0.000 claims description 4
- VECSJEDODMVSJD-UHFFFAOYSA-N 1-hydroxy-1-pentan-3-yl-3-(3-phenoxyphenyl)urea Chemical compound CCC(CC)N(O)C(=O)NC1=CC=CC(OC=2C=CC=CC=2)=C1 VECSJEDODMVSJD-UHFFFAOYSA-N 0.000 claims description 4
- ZIGHLRAVHFVRLS-UHFFFAOYSA-N 1-hydroxy-1-pentan-3-yl-3-(4-phenoxyphenyl)urea Chemical compound C1=CC(NC(=O)N(O)C(CC)CC)=CC=C1OC1=CC=CC=C1 ZIGHLRAVHFVRLS-UHFFFAOYSA-N 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 201000004681 Psoriasis Diseases 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 4
- 208000006673 asthma Diseases 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 4
- CBMUGPKLGKEKPR-UHFFFAOYSA-N 1-cyclooctyl-1-hydroxy-3-(4-methoxyphenyl)urea Chemical compound C1=CC(OC)=CC=C1NC(=O)N(O)C1CCCCCCC1 CBMUGPKLGKEKPR-UHFFFAOYSA-N 0.000 claims description 3
- PZNYUIZWTWKNFN-UHFFFAOYSA-N 1-cyclooctyl-1-hydroxy-3-(4-nitrophenyl)urea Chemical compound C=1C=C([N+]([O-])=O)C=CC=1NC(=O)N(O)C1CCCCCCC1 PZNYUIZWTWKNFN-UHFFFAOYSA-N 0.000 claims description 3
- ZIXVMWVNEMPRGS-UHFFFAOYSA-N 1-cyclooctyl-1-hydroxy-3-phenylurea Chemical compound C=1C=CC=CC=1NC(=O)N(O)C1CCCCCCC1 ZIXVMWVNEMPRGS-UHFFFAOYSA-N 0.000 claims description 3
- DNWGFUVAFNEYNQ-UHFFFAOYSA-N 1-hexan-3-yl-1-hydroxy-3-phenylurea Chemical compound CCCC(CC)N(O)C(=O)NC1=CC=CC=C1 DNWGFUVAFNEYNQ-UHFFFAOYSA-N 0.000 claims description 3
- GSRXBOYHYVEDAZ-UHFFFAOYSA-N 1-hydroxy-1,3-dimethyl-3-phenylurea Chemical compound CN(O)C(=O)N(C)C1=CC=CC=C1 GSRXBOYHYVEDAZ-UHFFFAOYSA-N 0.000 claims description 3
- MIKNAGBXJJFBMH-UHFFFAOYSA-N 1-hydroxy-1-(2-methylpropyl)-3-phenylurea Chemical compound CC(C)CN(O)C(=O)NC1=CC=CC=C1 MIKNAGBXJJFBMH-UHFFFAOYSA-N 0.000 claims description 3
- KHRWQJXWOOYBPJ-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-(4-methylsulfanylphenyl)urea Chemical compound CSC1=CC=C(NC(=O)N(C)O)C=C1 KHRWQJXWOOYBPJ-UHFFFAOYSA-N 0.000 claims description 3
- GHPVQGDLTYEKSE-UHFFFAOYSA-N 1-hydroxy-1-pentan-2-yl-3-phenylurea Chemical compound CCCC(C)N(O)C(=O)NC1=CC=CC=C1 GHPVQGDLTYEKSE-UHFFFAOYSA-N 0.000 claims description 3
- JLGFYLIGAKBPIM-UHFFFAOYSA-N 1-hydroxy-1-pentan-3-yl-3-(4-phenylphenyl)urea Chemical compound C1=CC(NC(=O)N(O)C(CC)CC)=CC=C1C1=CC=CC=C1 JLGFYLIGAKBPIM-UHFFFAOYSA-N 0.000 claims description 3
- YLBOOZRFNPXAAQ-UHFFFAOYSA-N 1-hydroxy-1-pentan-3-yl-3-phenylurea Chemical compound CCC(CC)N(O)C(=O)NC1=CC=CC=C1 YLBOOZRFNPXAAQ-UHFFFAOYSA-N 0.000 claims description 3
- VTRVQCIHWKQEBO-UHFFFAOYSA-N 3-(4-benzoylphenyl)-1-hydroxy-1-pentan-3-ylurea Chemical compound C1=CC(NC(=O)N(O)C(CC)CC)=CC=C1C(=O)C1=CC=CC=C1 VTRVQCIHWKQEBO-UHFFFAOYSA-N 0.000 claims description 3
- SSGRIYXOSFWTLN-UHFFFAOYSA-N 3-(4-butylphenyl)-1-hydroxy-1-propan-2-ylurea Chemical compound CCCCC1=CC=C(NC(=O)N(O)C(C)C)C=C1 SSGRIYXOSFWTLN-UHFFFAOYSA-N 0.000 claims description 3
- BAYJIVICNBMRFH-UHFFFAOYSA-N 3-[3,5-bis(trifluoromethyl)phenyl]-1-hydroxy-1-pentan-3-ylurea Chemical compound CCC(CC)N(O)C(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 BAYJIVICNBMRFH-UHFFFAOYSA-N 0.000 claims description 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims description 3
- 201000005569 Gout Diseases 0.000 claims description 3
- 206010063837 Reperfusion injury Diseases 0.000 claims description 3
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims description 3
- 206010039085 Rhinitis allergic Diseases 0.000 claims description 3
- 208000006011 Stroke Diseases 0.000 claims description 3
- 208000030886 Traumatic Brain injury Diseases 0.000 claims description 3
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims description 3
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 125000005036 alkoxyphenyl group Chemical group 0.000 claims description 3
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 3
- 201000010105 allergic rhinitis Diseases 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 230000000302 ischemic effect Effects 0.000 claims description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 3
- 208000020431 spinal cord injury Diseases 0.000 claims description 3
- 230000009529 traumatic brain injury Effects 0.000 claims description 3
- GXENJOBLVCZEBW-UHFFFAOYSA-N 1-(2-ethoxyethyl)-1-hydroxy-3-phenylurea Chemical compound CCOCCN(O)C(=O)NC1=CC=CC=C1 GXENJOBLVCZEBW-UHFFFAOYSA-N 0.000 claims description 2
- SKCXCIJPVDTWDU-UHFFFAOYSA-N 1-(2-ethylhexyl)-1-hydroxy-3-phenylurea Chemical compound CCCCC(CC)CN(O)C(=O)NC1=CC=CC=C1 SKCXCIJPVDTWDU-UHFFFAOYSA-N 0.000 claims description 2
- XRKPPGJZSHRPRE-UHFFFAOYSA-N 1-cyclohexyl-1-hydroxy-3-(3-methylsulfanylphenyl)urea Chemical compound CSC1=CC=CC(NC(=O)N(O)C2CCCCC2)=C1 XRKPPGJZSHRPRE-UHFFFAOYSA-N 0.000 claims description 2
- PBKRZGRQYPZDOF-UHFFFAOYSA-N 1-cyclohexyl-1-hydroxy-3-(4-methylsulfanylphenyl)urea Chemical compound C1=CC(SC)=CC=C1NC(=O)N(O)C1CCCCC1 PBKRZGRQYPZDOF-UHFFFAOYSA-N 0.000 claims description 2
- IQMDJGZTJBEXBE-UHFFFAOYSA-N 1-ethyl-1-hydroxy-3-phenylurea Chemical compound CCN(O)C(=O)NC1=CC=CC=C1 IQMDJGZTJBEXBE-UHFFFAOYSA-N 0.000 claims description 2
- QEHHVWCTLFFYGB-UHFFFAOYSA-N 1-hydroxy-1-(2-methylpropyl)-3-(3-methylsulfanylphenyl)urea Chemical compound CSC1=CC=CC(NC(=O)N(O)CC(C)C)=C1 QEHHVWCTLFFYGB-UHFFFAOYSA-N 0.000 claims description 2
- DNDYVCLCRSOGAM-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-(3-methylphenyl)urea Chemical compound CN(O)C(=O)NC1=CC=CC(C)=C1 DNDYVCLCRSOGAM-UHFFFAOYSA-N 0.000 claims description 2
- CDFBRZWZPFQLHK-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-(3-methylsulfonylphenyl)urea Chemical compound CN(O)C(=O)NC1=CC=CC(S(C)(=O)=O)=C1 CDFBRZWZPFQLHK-UHFFFAOYSA-N 0.000 claims description 2
- SXQIEPLNJQLXPK-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-(3-nitrophenyl)urea Chemical compound CN(O)C(=O)NC1=CC=CC([N+]([O-])=O)=C1 SXQIEPLNJQLXPK-UHFFFAOYSA-N 0.000 claims description 2
- QLCSFOCEFMIXJU-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-(4-methylsulfinylphenyl)urea Chemical compound CN(O)C(=O)NC1=CC=C(S(C)=O)C=C1 QLCSFOCEFMIXJU-UHFFFAOYSA-N 0.000 claims description 2
- INWTVKADJULPBO-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-(4-methylsulfonylphenyl)urea Chemical compound CN(O)C(=O)NC1=CC=C(S(C)(=O)=O)C=C1 INWTVKADJULPBO-UHFFFAOYSA-N 0.000 claims description 2
- QDWDPUOZHMWVAO-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-(4-nitrophenyl)urea Chemical compound CN(O)C(=O)NC1=CC=C([N+]([O-])=O)C=C1 QDWDPUOZHMWVAO-UHFFFAOYSA-N 0.000 claims description 2
- WDFAHNFQLHAIAW-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-phenylurea Chemical compound CN(O)C(=O)NC1=CC=CC=C1 WDFAHNFQLHAIAW-UHFFFAOYSA-N 0.000 claims description 2
- MBKLOKZYMMIOPI-UHFFFAOYSA-N 1-hydroxy-1-octyl-3-phenylurea Chemical compound CCCCCCCCN(O)C(=O)NC1=CC=CC=C1 MBKLOKZYMMIOPI-UHFFFAOYSA-N 0.000 claims description 2
- GBUJJTWYBQXKMP-UHFFFAOYSA-N 1-hydroxy-1-propan-2-yl-3-(3,4,5-trimethoxyphenyl)urea Chemical compound COC1=CC(NC(=O)N(O)C(C)C)=CC(OC)=C1OC GBUJJTWYBQXKMP-UHFFFAOYSA-N 0.000 claims description 2
- KIXWCQGCSDSZJP-UHFFFAOYSA-N 1-hydroxy-3-(3-methoxyphenyl)-1-methylurea Chemical compound COC1=CC=CC(NC(=O)N(C)O)=C1 KIXWCQGCSDSZJP-UHFFFAOYSA-N 0.000 claims description 2
- JFTXXIWGINAPRW-UHFFFAOYSA-N 1-hydroxy-3-(3-methylphenyl)-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=CC(C)=C1 JFTXXIWGINAPRW-UHFFFAOYSA-N 0.000 claims description 2
- ABSAVCDABIYUSR-UHFFFAOYSA-N 1-hydroxy-3-(4-methoxyphenyl)-1-propan-2-ylurea Chemical compound COC1=CC=C(NC(=O)N(O)C(C)C)C=C1 ABSAVCDABIYUSR-UHFFFAOYSA-N 0.000 claims description 2
- VMAJNRVBTRLLFF-UHFFFAOYSA-N 1-hydroxy-3-(4-methylsulfanylphenyl)-1-pentan-3-ylurea Chemical compound CCC(CC)N(O)C(=O)NC1=CC=C(SC)C=C1 VMAJNRVBTRLLFF-UHFFFAOYSA-N 0.000 claims description 2
- PVUSGHXDOQZRHB-UHFFFAOYSA-N 1-hydroxy-3-(4-methylsulfanylphenyl)-1-propan-2-ylurea Chemical compound CSC1=CC=C(NC(=O)N(O)C(C)C)C=C1 PVUSGHXDOQZRHB-UHFFFAOYSA-N 0.000 claims description 2
- GJHPFNVPBFZSBZ-UHFFFAOYSA-N 1-hydroxy-3-(4-methylsulfinylphenyl)-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=C(S(C)=O)C=C1 GJHPFNVPBFZSBZ-UHFFFAOYSA-N 0.000 claims description 2
- SRYYGLFBFPLVKS-UHFFFAOYSA-N 1-hydroxy-3-(4-methylsulfonylphenyl)-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=C(S(C)(=O)=O)C=C1 SRYYGLFBFPLVKS-UHFFFAOYSA-N 0.000 claims description 2
- ZKYGFQZYEHOHFT-UHFFFAOYSA-N 1-hydroxy-3-methyl-1-pentan-3-yl-3-phenylurea Chemical compound CCC(CC)N(O)C(=O)N(C)C1=CC=CC=C1 ZKYGFQZYEHOHFT-UHFFFAOYSA-N 0.000 claims description 2
- YXIQIWGBXUWPMP-UHFFFAOYSA-N 1-hydroxy-3-phenyl-1-propylurea Chemical compound CCCN(O)C(=O)NC1=CC=CC=C1 YXIQIWGBXUWPMP-UHFFFAOYSA-N 0.000 claims description 2
- XOUHVHLQDLQVGK-UHFFFAOYSA-N 3-(2,6-dimethylphenyl)-1-hydroxy-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=C(C)C=CC=C1C XOUHVHLQDLQVGK-UHFFFAOYSA-N 0.000 claims description 2
- TUNLIDHDEAPGFH-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-hydroxy-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=CC=C1Cl TUNLIDHDEAPGFH-UHFFFAOYSA-N 0.000 claims description 2
- UWRRNHUJMVRJQM-UHFFFAOYSA-N 3-(3-bromophenyl)-1-hydroxy-1-methylurea Chemical compound CN(O)C(=O)NC1=CC=CC(Br)=C1 UWRRNHUJMVRJQM-UHFFFAOYSA-N 0.000 claims description 2
- SSWQQXXNXZZMGI-UHFFFAOYSA-N 3-(3-fluorophenyl)-1-hydroxy-1-methylurea Chemical compound CN(O)C(=O)NC1=CC=CC(F)=C1 SSWQQXXNXZZMGI-UHFFFAOYSA-N 0.000 claims description 2
- PYOOIHLAZICISI-UHFFFAOYSA-N 3-(4-benzylphenyl)-1-hydroxy-1-pentan-3-ylurea Chemical compound C1=CC(NC(=O)N(O)C(CC)CC)=CC=C1CC1=CC=CC=C1 PYOOIHLAZICISI-UHFFFAOYSA-N 0.000 claims description 2
- KXNBJEAIJGHRTA-UHFFFAOYSA-N 3-(4-bromophenyl)-1-hydroxy-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=C(Br)C=C1 KXNBJEAIJGHRTA-UHFFFAOYSA-N 0.000 claims description 2
- LMSPXPMFWLBACP-UHFFFAOYSA-N 3-(4-fluorophenyl)-1-hydroxy-1-methylurea Chemical compound CN(O)C(=O)NC1=CC=C(F)C=C1 LMSPXPMFWLBACP-UHFFFAOYSA-N 0.000 claims description 2
- OZGAHZOKLMNWLQ-UHFFFAOYSA-N 3-(4-fluorophenyl)-1-hydroxy-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=C(F)C=C1 OZGAHZOKLMNWLQ-UHFFFAOYSA-N 0.000 claims description 2
- 206010003246 arthritis Diseases 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000000062 cyclohexylmethoxy group Chemical group [H]C([H])(O*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 201000008482 osteoarthritis Diseases 0.000 claims description 2
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 claims description 2
- 230000008687 biosynthesis inhibition Effects 0.000 claims 2
- PXHXUXKVWDYSND-UHFFFAOYSA-N 1-(3,3-dimethylbutyl)-1-hydroxy-3-phenylurea Chemical compound CC(C)(C)CCN(O)C(=O)NC1=CC=CC=C1 PXHXUXKVWDYSND-UHFFFAOYSA-N 0.000 claims 1
- UVEHEHCJUFXWCZ-UHFFFAOYSA-N 1-dodecyl-1-hydroxy-3-phenylurea Chemical compound CCCCCCCCCCCCN(O)C(=O)NC1=CC=CC=C1 UVEHEHCJUFXWCZ-UHFFFAOYSA-N 0.000 claims 1
- ZBSGSLMODOMPLS-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-(3-methylsulfanylphenyl)urea Chemical compound CSC1=CC=CC(NC(=O)N(C)O)=C1 ZBSGSLMODOMPLS-UHFFFAOYSA-N 0.000 claims 1
- NNVZEWRBSYYQNV-UHFFFAOYSA-N 1-hydroxy-1-methyl-3-[3-(trifluoromethylsulfanyl)phenyl]urea Chemical compound CN(O)C(=O)NC1=CC=CC(SC(F)(F)F)=C1 NNVZEWRBSYYQNV-UHFFFAOYSA-N 0.000 claims 1
- KXSOXBWDIOUMTD-UHFFFAOYSA-N 1-hydroxy-1-pentan-3-yl-3-(4-phenylmethoxyphenyl)urea Chemical compound C1=CC(NC(=O)N(O)C(CC)CC)=CC=C1OCC1=CC=CC=C1 KXSOXBWDIOUMTD-UHFFFAOYSA-N 0.000 claims 1
- BFPVIYCFRMYRHI-UHFFFAOYSA-N 1-hydroxy-1-pentan-3-yl-3-[4-(3-phenylpropoxy)phenyl]urea Chemical compound C1=CC(NC(=O)N(O)C(CC)CC)=CC=C1OCCCC1=CC=CC=C1 BFPVIYCFRMYRHI-UHFFFAOYSA-N 0.000 claims 1
- DVGZQCMFBFLIAP-UHFFFAOYSA-N 1-hydroxy-1-pentyl-3-phenylurea Chemical compound CCCCCN(O)C(=O)NC1=CC=CC=C1 DVGZQCMFBFLIAP-UHFFFAOYSA-N 0.000 claims 1
- VKJLLJNTGFUPGY-UHFFFAOYSA-N 1-hydroxy-3-(2-methoxyphenyl)-1-propan-2-ylurea Chemical compound COC1=CC=CC=C1NC(=O)N(O)C(C)C VKJLLJNTGFUPGY-UHFFFAOYSA-N 0.000 claims 1
- WKGJWLKNCYKNLL-UHFFFAOYSA-N 1-hydroxy-3-(3-methoxyphenyl)-1-propan-2-ylurea Chemical compound COC1=CC=CC(NC(=O)N(O)C(C)C)=C1 WKGJWLKNCYKNLL-UHFFFAOYSA-N 0.000 claims 1
- RIXFGCFCRAYTAY-UHFFFAOYSA-N 1-hydroxy-3-(4-nitrophenyl)-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=C([N+]([O-])=O)C=C1 RIXFGCFCRAYTAY-UHFFFAOYSA-N 0.000 claims 1
- OZKAEAQFYFRPJW-UHFFFAOYSA-N 1-hydroxy-3-phenyl-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=CC=C1 OZKAEAQFYFRPJW-UHFFFAOYSA-N 0.000 claims 1
- ITVQLDIOEIQRLO-UHFFFAOYSA-N 3-(2,5-dimethoxyphenyl)-1-hydroxy-1-propan-2-ylurea Chemical compound COC1=CC=C(OC)C(NC(=O)N(O)C(C)C)=C1 ITVQLDIOEIQRLO-UHFFFAOYSA-N 0.000 claims 1
- MHWOAOIGPMCZJW-UHFFFAOYSA-N 3-(3-cyclopentyloxy-4-methoxyphenyl)-1-hydroxy-1-pentan-3-ylurea Chemical compound CCC(CC)N(O)C(=O)NC1=CC=C(OC)C(OC2CCCC2)=C1 MHWOAOIGPMCZJW-UHFFFAOYSA-N 0.000 claims 1
- KPYKRDVPHVGXMO-UHFFFAOYSA-N 3-[4-(cyclohexylmethoxy)phenyl]-1-hydroxy-1-pentan-3-ylurea Chemical compound C1=CC(NC(=O)N(O)C(CC)CC)=CC=C1OCC1CCCCC1 KPYKRDVPHVGXMO-UHFFFAOYSA-N 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 claims 1
- OOBHKEXLUONANP-UHFFFAOYSA-N ethyl 6-[hydroxy(phenylcarbamoyl)amino]hexanoate Chemical compound CCOC(=O)CCCCCN(O)C(=O)NC1=CC=CC=C1 OOBHKEXLUONANP-UHFFFAOYSA-N 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000003680 myocardial damage Effects 0.000 claims 1
- 125000002071 phenylalkoxy group Chemical group 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 55
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 87
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 85
- 239000007787 solid Substances 0.000 description 59
- 238000006243 chemical reaction Methods 0.000 description 55
- 239000000243 solution Substances 0.000 description 55
- 238000004458 analytical method Methods 0.000 description 47
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 43
- 239000011541 reaction mixture Substances 0.000 description 41
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 39
- 239000000047 product Substances 0.000 description 39
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 235000013877 carbamide Nutrition 0.000 description 28
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 26
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 description 23
- 239000000203 mixture Substances 0.000 description 23
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- 239000012948 isocyanate Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 150000002513 isocyanates Chemical class 0.000 description 17
- GWNVDXQDILPJIG-NXOLIXFESA-N leukotriene C4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O GWNVDXQDILPJIG-NXOLIXFESA-N 0.000 description 15
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- NVEFQYHCCMKEOO-UHFFFAOYSA-N n-pentan-3-ylhydroxylamine Chemical compound CCC(CC)NO NVEFQYHCCMKEOO-UHFFFAOYSA-N 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 13
- 235000019341 magnesium sulphate Nutrition 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- 235000002639 sodium chloride Nutrition 0.000 description 12
- 229910000104 sodium hydride Inorganic materials 0.000 description 12
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 11
- 239000012043 crude product Substances 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
- 101100545004 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YSP2 gene Proteins 0.000 description 10
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 10
- 239000012312 sodium hydride Substances 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 229940125936 compound 42 Drugs 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- AGVZBCZHWKBGBO-UHFFFAOYSA-N 1-phenyl-3-phenylmethoxyurea Chemical compound C=1C=CC=CC=1NC(=O)NOCC1=CC=CC=C1 AGVZBCZHWKBGBO-UHFFFAOYSA-N 0.000 description 8
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 8
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 8
- HYDZPXNVHXJHBG-UHFFFAOYSA-N o-benzylhydroxylamine;hydron;chloride Chemical compound Cl.NOCC1=CC=CC=C1 HYDZPXNVHXJHBG-UHFFFAOYSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 239000007983 Tris buffer Substances 0.000 description 7
- 239000001569 carbon dioxide Substances 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- MZNBNPWFHGWAGH-UHFFFAOYSA-N tert-butyl n-phenylmethoxycarbamate Chemical compound CC(C)(C)OC(=O)NOCC1=CC=CC=C1 MZNBNPWFHGWAGH-UHFFFAOYSA-N 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 7
- 229920002307 Dextran Polymers 0.000 description 6
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 229940125904 compound 1 Drugs 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000003818 flash chromatography Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 239000002480 mineral oil Substances 0.000 description 6
- 235000010446 mineral oil Nutrition 0.000 description 6
- XYEOALKITRFCJJ-UHFFFAOYSA-N o-benzylhydroxylamine Chemical compound NOCC1=CC=CC=C1 XYEOALKITRFCJJ-UHFFFAOYSA-N 0.000 description 6
- IXRIVZOKBPYSPK-UHFFFAOYSA-N phenylmethoxyurea Chemical compound NC(=O)NOCC1=CC=CC=C1 IXRIVZOKBPYSPK-UHFFFAOYSA-N 0.000 description 6
- 241000282472 Canis lupus familiaris Species 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 5
- GWNVDXQDILPJIG-SHSCPDMUSA-N Leukotriene C4 Natural products CCCCCC=C/CC=C/C=C/C=C/C(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C(O)CCCC(=O)O GWNVDXQDILPJIG-SHSCPDMUSA-N 0.000 description 5
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 5
- 239000012259 ether extract Substances 0.000 description 5
- 229960001330 hydroxycarbamide Drugs 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 230000005291 magnetic effect Effects 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- 238000003127 radioimmunoassay Methods 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical group BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 4
- QNKQBDZVEKZFBN-UHFFFAOYSA-N 1-isocyanato-4-methylsulfanylbenzene Chemical compound CSC1=CC=C(N=C=O)C=C1 QNKQBDZVEKZFBN-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical group OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229960002897 heparin Drugs 0.000 description 4
- 229920000669 heparin Polymers 0.000 description 4
- 238000007327 hydrogenolysis reaction Methods 0.000 description 4
- JOASPLCDBDCRJJ-UHFFFAOYSA-N n-cyclooctylhydroxylamine Chemical compound ONC1CCCCCCC1 JOASPLCDBDCRJJ-UHFFFAOYSA-N 0.000 description 4
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 3
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 3
- BKJABLMNBSVKCV-UHFFFAOYSA-N 1-isocyanato-3-methylsulfanylbenzene Chemical compound CSC1=CC=CC(N=C=O)=C1 BKJABLMNBSVKCV-UHFFFAOYSA-N 0.000 description 3
- HIYAVKIYRIFSCZ-CYEMHPAKSA-N 5-(methylamino)-2-[[(2S,3R,5R,6S,8R,9R)-3,5,9-trimethyl-2-[(2S)-1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid Chemical compound O=C([C@@H](C)[C@H]1O[C@@]2([C@@H](C[C@H]1C)C)O[C@@H]([C@@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C1=CC=CN1 HIYAVKIYRIFSCZ-CYEMHPAKSA-N 0.000 description 3
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 3
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 239000003710 calcium ionophore Substances 0.000 description 3
- HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940125758 compound 15 Drugs 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- CJAONIOAQZUHPN-KKLWWLSJSA-N ethyl 12-[[2-[(2r,3r)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate Chemical compound CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC CJAONIOAQZUHPN-KKLWWLSJSA-N 0.000 description 3
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- BYXUIKZQGOPKFR-UHFFFAOYSA-N hydron;n-propan-2-ylhydroxylamine;chloride Chemical compound Cl.CC(C)NO BYXUIKZQGOPKFR-UHFFFAOYSA-N 0.000 description 3
- 238000012417 linear regression Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 239000003880 polar aprotic solvent Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 2
- YNEVZCRFIPMXRN-UHFFFAOYSA-N 1,3-dimethyl-1-phenyl-3-phenylmethoxyurea Chemical compound C=1C=CC=CC=1N(C)C(=O)N(C)OCC1=CC=CC=C1 YNEVZCRFIPMXRN-UHFFFAOYSA-N 0.000 description 2
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- NZZVRDPNXYCGPW-UHFFFAOYSA-N 1-(2-methylpropyl)-3-phenyl-1-phenylmethoxyurea Chemical compound C=1C=CC=CC=1NC(=O)N(CC(C)C)OCC1=CC=CC=C1 NZZVRDPNXYCGPW-UHFFFAOYSA-N 0.000 description 2
- ZWKAYQCHZCCQJT-UHFFFAOYSA-N 1-(4-butylphenyl)-3-phenylmethoxyurea Chemical compound C1=CC(CCCC)=CC=C1NC(=O)NOCC1=CC=CC=C1 ZWKAYQCHZCCQJT-UHFFFAOYSA-N 0.000 description 2
- BZVNSFIEXQKURO-UHFFFAOYSA-N 1-butan-2-yl-3-phenyl-1-phenylmethoxyurea Chemical compound C=1C=CC=CC=1NC(=O)N(C(C)CC)OCC1=CC=CC=C1 BZVNSFIEXQKURO-UHFFFAOYSA-N 0.000 description 2
- ITLADWXNGIRATP-UHFFFAOYSA-N 1-hexan-3-yl-3-phenyl-1-phenylmethoxyurea Chemical compound C=1C=CC=CC=1NC(=O)N(C(CC)CCC)OCC1=CC=CC=C1 ITLADWXNGIRATP-UHFFFAOYSA-N 0.000 description 2
- MXUJUXFTGCXMIK-UHFFFAOYSA-N 1-hydroxy-1-propan-2-yl-3-(2,4,5-trimethylphenyl)urea Chemical compound CC(C)N(O)C(=O)NC1=CC(C)=C(C)C=C1C MXUJUXFTGCXMIK-UHFFFAOYSA-N 0.000 description 2
- JEMYMTHFRWMJMZ-UHFFFAOYSA-N 1-hydroxy-3-(4-nitrophenyl)-1-pentan-3-ylurea Chemical compound CCC(CC)N(O)C(=O)NC1=CC=C([N+]([O-])=O)C=C1 JEMYMTHFRWMJMZ-UHFFFAOYSA-N 0.000 description 2
- GFNKTLQTQSALEJ-UHFFFAOYSA-N 1-isocyanato-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(N=C=O)C=C1 GFNKTLQTQSALEJ-UHFFFAOYSA-N 0.000 description 2
- APCGCXGZJRDDPF-UHFFFAOYSA-N 1-methyl-1-phenyl-3-phenylmethoxyurea Chemical compound C=1C=CC=CC=1N(C)C(=O)NOCC1=CC=CC=C1 APCGCXGZJRDDPF-UHFFFAOYSA-N 0.000 description 2
- ZTOXRKQEVOHRMT-UHFFFAOYSA-N 1-methyl-3-pentan-3-yl-1-phenyl-3-phenylmethoxyurea Chemical compound C=1C=CC=CC=1N(C)C(=O)N(C(CC)CC)OCC1=CC=CC=C1 ZTOXRKQEVOHRMT-UHFFFAOYSA-N 0.000 description 2
- OKPBRMHNNGRQAX-UHFFFAOYSA-N 1-pentan-3-yl-3-phenyl-1-phenylmethoxyurea Chemical compound C=1C=CC=CC=1NC(=O)N(C(CC)CC)OCC1=CC=CC=C1 OKPBRMHNNGRQAX-UHFFFAOYSA-N 0.000 description 2
- PBRIFGDRQYNYBX-UHFFFAOYSA-N 2-methyl-n-phenylmethoxypropan-1-amine Chemical compound CC(C)CNOCC1=CC=CC=C1 PBRIFGDRQYNYBX-UHFFFAOYSA-N 0.000 description 2
- YPHXVNTZOIYJGI-UHFFFAOYSA-N 3-(4-bromophenyl)-1-hydroxy-1-pentan-3-ylurea Chemical compound CCC(CC)N(O)C(=O)NC1=CC=C(Br)C=C1 YPHXVNTZOIYJGI-UHFFFAOYSA-N 0.000 description 2
- OYYAZWBTEGSDNX-UHFFFAOYSA-N 3-(4-butylphenyl)-1-pentyl-1-phenylmethoxyurea Chemical compound C=1C=C(CCCC)C=CC=1NC(=O)N(CCCCC)OCC1=CC=CC=C1 OYYAZWBTEGSDNX-UHFFFAOYSA-N 0.000 description 2
- VTOQFOCYBTVOJZ-UHFFFAOYSA-N 3-bromopentane Chemical compound CCC(Br)CC VTOQFOCYBTVOJZ-UHFFFAOYSA-N 0.000 description 2
- FZFWPURYSWKIRT-UHFFFAOYSA-N 3-cyclopentyloxy-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1OC1CCCC1 FZFWPURYSWKIRT-UHFFFAOYSA-N 0.000 description 2
- RVADCQWIQKYXBJ-UHFFFAOYSA-N 3-cyclopentyloxy-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1OC1CCCC1 RVADCQWIQKYXBJ-UHFFFAOYSA-N 0.000 description 2
- ISYNAKAYWOEKFP-UHFFFAOYSA-N 4-(3-phenylpropoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OCCCC1=CC=CC=C1 ISYNAKAYWOEKFP-UHFFFAOYSA-N 0.000 description 2
- VVAQLOMOWIACOF-UHFFFAOYSA-N 4-(cyclohexylmethoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OCC1CCCCC1 VVAQLOMOWIACOF-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- IFQUPKAISSPFTE-UHFFFAOYSA-N 4-benzoylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(=O)C1=CC=CC=C1 IFQUPKAISSPFTE-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- 229940127007 Compound 39 Drugs 0.000 description 2
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 2
- NDCGVLJXFQKXOF-UHFFFAOYSA-N N-hydroxy-2-methylpropanamine Chemical compound CC(C)CNO NDCGVLJXFQKXOF-UHFFFAOYSA-N 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000012754 cardiac puncture Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229940125878 compound 36 Drugs 0.000 description 2
- 229940126179 compound 72 Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- SSVAHXZUFFSFER-UHFFFAOYSA-N cyclohexyl(hydroxy)azanium;chloride Chemical compound Cl.ONC1CCCCC1 SSVAHXZUFFSFER-UHFFFAOYSA-N 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- RGZRSLKIOCHTSI-UHFFFAOYSA-N hydron;n-methylhydroxylamine;chloride Chemical compound Cl.CNO RGZRSLKIOCHTSI-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- OPOQLTUWTGBFCO-UHFFFAOYSA-N methyl 4-(3-phenylpropoxy)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1OCCCC1=CC=CC=C1 OPOQLTUWTGBFCO-UHFFFAOYSA-N 0.000 description 2
- XLMVRKFZNFZUNP-UHFFFAOYSA-N methyl 4-(cyclohexylmethoxy)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1OCC1CCCCC1 XLMVRKFZNFZUNP-UHFFFAOYSA-N 0.000 description 2
- MXOCZJKMELIXSG-UHFFFAOYSA-N methyl 4-[(4-methylphenyl)methoxy]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1OCC1=CC=C(C)C=C1 MXOCZJKMELIXSG-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 208000037891 myocardial injury Diseases 0.000 description 2
- KTPUHSVFNHULJH-UHFFFAOYSA-N n-cyclooctylidenehydroxylamine Chemical compound ON=C1CCCCCCC1 KTPUHSVFNHULJH-UHFFFAOYSA-N 0.000 description 2
- CPGWSLFYXMRNDV-UHFFFAOYSA-N n-methyl-n-phenylcarbamoyl chloride Chemical compound ClC(=O)N(C)C1=CC=CC=C1 CPGWSLFYXMRNDV-UHFFFAOYSA-N 0.000 description 2
- NAQQTJZRCYNBRX-UHFFFAOYSA-N n-pentan-3-ylidenehydroxylamine Chemical compound CCC(CC)=NO NAQQTJZRCYNBRX-UHFFFAOYSA-N 0.000 description 2
- IANNBWVHGOIPRN-UHFFFAOYSA-N n-phenylmethoxymethanamine Chemical compound CNOCC1=CC=CC=C1 IANNBWVHGOIPRN-UHFFFAOYSA-N 0.000 description 2
- KVQQACCDQYFLDI-UHFFFAOYSA-N n-phenylmethoxypentan-3-amine Chemical compound CCC(CC)NOCC1=CC=CC=C1 KVQQACCDQYFLDI-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 210000003200 peritoneal cavity Anatomy 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- LVOHXXLQQXHPDR-UHFFFAOYSA-N tert-butyl n-(2-methylpropyl)-n-phenylmethoxycarbamate Chemical compound CC(C)(C)OC(=O)N(CC(C)C)OCC1=CC=CC=C1 LVOHXXLQQXHPDR-UHFFFAOYSA-N 0.000 description 2
- UIMNSSAARJCYKA-UHFFFAOYSA-N tert-butyl n-pentan-3-yl-n-phenylmethoxycarbamate Chemical compound CC(C)(C)OC(=O)N(C(CC)CC)OCC1=CC=CC=C1 UIMNSSAARJCYKA-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- QXOGPTXQGKQSJT-UHFFFAOYSA-N 1-amino-4-[4-(3,4-dimethylphenyl)sulfanylanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound Cc1ccc(Sc2ccc(Nc3cc(c(N)c4C(=O)c5ccccc5C(=O)c34)S(O)(=O)=O)cc2)cc1C QXOGPTXQGKQSJT-UHFFFAOYSA-N 0.000 description 1
- HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 1
- CZQIJQFTRGDODI-UHFFFAOYSA-N 1-bromo-4-isocyanatobenzene Chemical compound BrC1=CC=C(N=C=O)C=C1 CZQIJQFTRGDODI-UHFFFAOYSA-N 0.000 description 1
- YZWKKMVJZFACSU-UHFFFAOYSA-N 1-bromopentane Chemical compound CCCCCBr YZWKKMVJZFACSU-UHFFFAOYSA-N 0.000 description 1
- LJJRXPXDTAUVQU-UHFFFAOYSA-N 1-butyl-4-isocyanatobenzene Chemical compound CCCCC1=CC=C(N=C=O)C=C1 LJJRXPXDTAUVQU-UHFFFAOYSA-N 0.000 description 1
- RFEFBUIAHGVPRU-UHFFFAOYSA-N 1-cycloheptyl-1-hydroxy-3-phenylurea Chemical compound C=1C=CC=CC=1NC(=O)N(O)C1CCCCCC1 RFEFBUIAHGVPRU-UHFFFAOYSA-N 0.000 description 1
- LUMBOLLDHYAILL-UHFFFAOYSA-N 1-heptan-4-yl-3-phenyl-1-phenylmethoxyurea Chemical compound C=1C=CC=CC=1NC(=O)N(C(CCC)CCC)OCC1=CC=CC=C1 LUMBOLLDHYAILL-UHFFFAOYSA-N 0.000 description 1
- LLOXEIGCZVCFCF-UHFFFAOYSA-N 1-hydroxy-1-(3-methylbutyl)-3-phenylurea Chemical compound CC(C)CCN(O)C(=O)NC1=CC=CC=C1 LLOXEIGCZVCFCF-UHFFFAOYSA-N 0.000 description 1
- KLNYSYVVAMFQQW-UHFFFAOYSA-N 1-hydroxy-3-(2-methylphenyl)-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=CC=C1C KLNYSYVVAMFQQW-UHFFFAOYSA-N 0.000 description 1
- SREDERTYQHPCSF-UHFFFAOYSA-N 1-hydroxy-3-(3-methylsulfanylphenyl)-1-propan-2-ylurea Chemical compound CSC1=CC=CC(NC(=O)N(O)C(C)C)=C1 SREDERTYQHPCSF-UHFFFAOYSA-N 0.000 description 1
- IPSNHSKZYFOBDG-UHFFFAOYSA-N 1-hydroxy-3-(3-methylsulfonylphenyl)-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=CC(S(C)(=O)=O)=C1 IPSNHSKZYFOBDG-UHFFFAOYSA-N 0.000 description 1
- ZWQACRFRUPGGBF-UHFFFAOYSA-N 1-hydroxy-3-[4-(4-octoxyphenyl)phenyl]-1-pentan-3-ylurea Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1=CC=C(NC(=O)N(O)C(CC)CC)C=C1 ZWQACRFRUPGGBF-UHFFFAOYSA-N 0.000 description 1
- MAIFYUSBGLFXDA-UHFFFAOYSA-N 1-isocyanato-2,4,5-trimethylbenzene Chemical compound CC1=CC(C)=C(N=C=O)C=C1C MAIFYUSBGLFXDA-UHFFFAOYSA-N 0.000 description 1
- NRSSOFNMWSJECS-UHFFFAOYSA-N 1-isocyanato-3,5-bis(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC(N=C=O)=CC(C(F)(F)F)=C1 NRSSOFNMWSJECS-UHFFFAOYSA-N 0.000 description 1
- FMDGXCSMDZMDHZ-UHFFFAOYSA-N 1-isocyanato-4-methoxybenzene Chemical compound COC1=CC=C(N=C=O)C=C1 FMDGXCSMDZMDHZ-UHFFFAOYSA-N 0.000 description 1
- PNBUGOFIKAHZRW-UHFFFAOYSA-N 1-isocyanato-4-phenoxybenzene Chemical compound C1=CC(N=C=O)=CC=C1OC1=CC=CC=C1 PNBUGOFIKAHZRW-UHFFFAOYSA-N 0.000 description 1
- LUGYVIXJUQDSMU-UHFFFAOYSA-N 1-methyl-3-(3-methylsulfonylphenyl)-1-phenylmethoxyurea Chemical compound C=1C=CC(S(C)(=O)=O)=CC=1NC(=O)N(C)OCC1=CC=CC=C1 LUGYVIXJUQDSMU-UHFFFAOYSA-N 0.000 description 1
- LKUJOVCVJONTLA-UHFFFAOYSA-N 1-pentan-2-yl-3-phenyl-1-phenylmethoxyurea Chemical compound C=1C=CC=CC=1NC(=O)N(C(C)CCC)OCC1=CC=CC=C1 LKUJOVCVJONTLA-UHFFFAOYSA-N 0.000 description 1
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 1
- UPSXAPQYNGXVBF-UHFFFAOYSA-N 2-bromobutane Chemical compound CCC(C)Br UPSXAPQYNGXVBF-UHFFFAOYSA-N 0.000 description 1
- LGAJYTCRJPCZRJ-UHFFFAOYSA-N 2-bromopentane Chemical compound CCCC(C)Br LGAJYTCRJPCZRJ-UHFFFAOYSA-N 0.000 description 1
- PKRSYEPBQPFNRB-UHFFFAOYSA-N 2-phenoxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC1=CC=CC=C1 PKRSYEPBQPFNRB-UHFFFAOYSA-N 0.000 description 1
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 1
- OAJQECFVQDLYAB-UHFFFAOYSA-N 3-(2-fluorophenyl)-1-hydroxy-1-propan-2-ylurea Chemical compound CC(C)N(O)C(=O)NC1=CC=CC=C1F OAJQECFVQDLYAB-UHFFFAOYSA-N 0.000 description 1
- IEYYABLWAPKHAL-UHFFFAOYSA-N 3-(4-butylphenyl)-1-hydroxy-1-methylurea Chemical compound CCCCC1=CC=C(NC(=O)N(C)O)C=C1 IEYYABLWAPKHAL-UHFFFAOYSA-N 0.000 description 1
- KHVDAUANVLBMCL-UHFFFAOYSA-N 3-(4-butylphenyl)-1-hydroxy-1-pentylurea Chemical compound CCCCCN(O)C(=O)NC1=CC=C(CCCC)C=C1 KHVDAUANVLBMCL-UHFFFAOYSA-N 0.000 description 1
- IOZOJWNUKLCDML-UHFFFAOYSA-N 3-bromohexane Chemical compound CCCC(Br)CC IOZOJWNUKLCDML-UHFFFAOYSA-N 0.000 description 1
- XMZQWZJMTBCUFT-UHFFFAOYSA-N 3-bromopropylbenzene Chemical compound BrCCCC1=CC=CC=C1 XMZQWZJMTBCUFT-UHFFFAOYSA-N 0.000 description 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- NXTDJHZGHOFSQG-UHFFFAOYSA-N 3-phenoxybenzoic acid Chemical compound OC(=O)C1=CC=CC(OC=2C=CC=CC=2)=C1 NXTDJHZGHOFSQG-UHFFFAOYSA-N 0.000 description 1
- YNBBQLUKHHSKPW-UHFFFAOYSA-N 4-(4-octoxyphenyl)benzoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1=CC=C(C(O)=O)C=C1 YNBBQLUKHHSKPW-UHFFFAOYSA-N 0.000 description 1
- FPHVRPCVNPHPBH-UHFFFAOYSA-N 4-benzylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CC1=CC=CC=C1 FPHVRPCVNPHPBH-UHFFFAOYSA-N 0.000 description 1
- BNUTXEKPXPZAIT-UHFFFAOYSA-N 4-bromoheptane Chemical compound CCCC(Br)CCC BNUTXEKPXPZAIT-UHFFFAOYSA-N 0.000 description 1
- NNJMFJSKMRYHSR-UHFFFAOYSA-N 4-phenylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=CC=C1 NNJMFJSKMRYHSR-UHFFFAOYSA-N 0.000 description 1
- AQSCHALQLXXKKC-UHFFFAOYSA-N 4-phenylmethoxybenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OCC1=CC=CC=C1 AQSCHALQLXXKKC-UHFFFAOYSA-N 0.000 description 1
- MJJXWPHZDBIHIM-UHFFFAOYSA-N 5-isocyanato-1,2,3-trimethoxybenzene Chemical compound COC1=CC(N=C=O)=CC(OC)=C1OC MJJXWPHZDBIHIM-UHFFFAOYSA-N 0.000 description 1
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 description 1
- 238000006085 Schmidt reaction Methods 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 229920000392 Zymosan Polymers 0.000 description 1
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 1
- VYWQTJWGWLKBQA-UHFFFAOYSA-N [amino(hydroxy)methylidene]azanium;chloride Chemical compound Cl.NC(N)=O VYWQTJWGWLKBQA-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 210000005091 airway smooth muscle Anatomy 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- BRTFVKHPEHKBQF-UHFFFAOYSA-N bromocyclopentane Chemical compound BrC1CCCC1 BRTFVKHPEHKBQF-UHFFFAOYSA-N 0.000 description 1
- UUWSLBWDFJMSFP-UHFFFAOYSA-N bromomethylcyclohexane Chemical compound BrCC1CCCCC1 UUWSLBWDFJMSFP-UHFFFAOYSA-N 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000005482 chemotactic factor Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- IIRFCWANHMSDCG-UHFFFAOYSA-N cyclooctanone Chemical compound O=C1CCCCCCC1 IIRFCWANHMSDCG-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 1
- 230000007247 enzymatic mechanism Effects 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 210000000224 granular leucocyte Anatomy 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 150000002443 hydroxylamines Chemical class 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- JVTZFYYHCGSXJV-UHFFFAOYSA-N isovanillin Chemical compound COC1=CC=C(C=O)C=C1O JVTZFYYHCGSXJV-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000020925 non fasting Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940100692 oral suspension Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- ALGXQPHPJWFWOU-UHFFFAOYSA-N tert-butyl n-hydroxy-n-(2-methylpropyl)carbamate Chemical compound CC(C)CN(O)C(=O)OC(C)(C)C ALGXQPHPJWFWOU-UHFFFAOYSA-N 0.000 description 1
- FAXXWRUSZMAJIR-UHFFFAOYSA-N tert-butyl n-methyl-n-phenylmethoxycarbamate Chemical compound CC(C)(C)OC(=O)N(C)OCC1=CC=CC=C1 FAXXWRUSZMAJIR-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28601794A | 1994-08-04 | 1994-08-04 | |
| US08/455,643 US5612377A (en) | 1994-08-04 | 1995-05-31 | Method of inhibiting leukotriene biosynthesis |
| PCT/US1995/007667 WO1996003983A1 (en) | 1994-08-04 | 1995-07-14 | Inhibition of leukotriene biosynthesis with urea derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO970477D0 NO970477D0 (no) | 1997-02-03 |
| NO970477L NO970477L (no) | 1997-03-14 |
| NO315786B1 true NO315786B1 (no) | 2003-10-27 |
Family
ID=26963530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19970477A NO315786B1 (no) | 1994-08-04 | 1997-02-03 | Inhibisjon av leukotrienbiosyntese med ureaderivater |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0777471B1 (fi) |
| JP (1) | JPH10503771A (fi) |
| AT (1) | ATE228359T1 (fi) |
| AU (1) | AU685980B2 (fi) |
| BR (1) | BR9508521A (fi) |
| CA (1) | CA2196701A1 (fi) |
| CZ (1) | CZ287034B6 (fi) |
| DE (1) | DE69528984T2 (fi) |
| DK (1) | DK0777471T3 (fi) |
| ES (1) | ES2185708T3 (fi) |
| FI (1) | FI970452A0 (fi) |
| HU (1) | HUT76830A (fi) |
| IL (1) | IL114646A (fi) |
| NO (1) | NO315786B1 (fi) |
| NZ (1) | NZ290236A (fi) |
| PL (1) | PL180668B1 (fi) |
| PT (1) | PT777471E (fi) |
| SK (1) | SK282777B6 (fi) |
| WO (1) | WO1996003983A1 (fi) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| FR2880022B1 (fr) * | 2004-12-24 | 2007-08-24 | Mayoly Spindler Soc Par Action | Nouveaux derives de la n-hydroxy-n'-phenyluree et de la n-hydroxy-n'-phenylthiouree et leur utilisation comme inhibiteurs de la synthese de la melanine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5066658A (en) * | 1988-11-10 | 1991-11-19 | Ortho Pharmaceutical Corporation | Substituted hydroxyureas |
| CA2046872A1 (en) * | 1989-02-01 | 1990-08-02 | Dee W. Brooks | Lipoxygenase inhibiting compounds |
| JP2528741B2 (ja) * | 1991-01-09 | 1996-08-28 | ファイザー製薬株式会社 | オキサゾ―ル、チアゾ―ルおよびイミダゾ―ル化合物 |
-
1995
- 1995-07-14 CZ CZ1997312A patent/CZ287034B6/cs not_active IP Right Cessation
- 1995-07-14 AT AT95926593T patent/ATE228359T1/de not_active IP Right Cessation
- 1995-07-14 CA CA002196701A patent/CA2196701A1/en not_active Abandoned
- 1995-07-14 DK DK95926593T patent/DK0777471T3/da active
- 1995-07-14 JP JP8506485A patent/JPH10503771A/ja not_active Withdrawn
- 1995-07-14 BR BR9508521A patent/BR9508521A/pt not_active Application Discontinuation
- 1995-07-14 ES ES95926593T patent/ES2185708T3/es not_active Expired - Lifetime
- 1995-07-14 SK SK110-97A patent/SK282777B6/sk unknown
- 1995-07-14 PT PT95926593T patent/PT777471E/pt unknown
- 1995-07-14 EP EP95926593A patent/EP0777471B1/en not_active Expired - Lifetime
- 1995-07-14 PL PL95318539A patent/PL180668B1/pl not_active IP Right Cessation
- 1995-07-14 HU HU9700338A patent/HUT76830A/hu unknown
- 1995-07-14 WO PCT/US1995/007667 patent/WO1996003983A1/en active IP Right Grant
- 1995-07-14 AU AU30917/95A patent/AU685980B2/en not_active Ceased
- 1995-07-14 NZ NZ290236A patent/NZ290236A/xx unknown
- 1995-07-14 DE DE69528984T patent/DE69528984T2/de not_active Expired - Fee Related
- 1995-07-18 IL IL11464695A patent/IL114646A/xx not_active IP Right Cessation
-
1997
- 1997-02-03 NO NO19970477A patent/NO315786B1/no unknown
- 1997-02-03 FI FI970452A patent/FI970452A0/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL180668B1 (pl) | 2001-03-30 |
| WO1996003983A1 (en) | 1996-02-15 |
| EP0777471A1 (en) | 1997-06-11 |
| PL318539A1 (en) | 1997-06-23 |
| EP0777471B1 (en) | 2002-11-27 |
| HUT76830A (en) | 1997-11-28 |
| DE69528984D1 (de) | 2003-01-09 |
| SK282777B6 (sk) | 2002-12-03 |
| NZ290236A (en) | 1998-12-23 |
| CA2196701A1 (en) | 1996-02-15 |
| CZ31297A3 (en) | 1997-09-17 |
| DK0777471T3 (da) | 2003-03-17 |
| IL114646A (en) | 2000-02-29 |
| NO970477L (no) | 1997-03-14 |
| MX9700860A (es) | 1997-10-31 |
| FI970452A (fi) | 1997-02-03 |
| IL114646A0 (en) | 1995-11-27 |
| ES2185708T3 (es) | 2003-05-01 |
| DE69528984T2 (de) | 2003-09-04 |
| FI970452A0 (fi) | 1997-02-03 |
| CZ287034B6 (en) | 2000-08-16 |
| NO970477D0 (no) | 1997-02-03 |
| ATE228359T1 (de) | 2002-12-15 |
| SK11097A3 (en) | 1997-09-10 |
| AU3091795A (en) | 1996-03-04 |
| PT777471E (pt) | 2003-04-30 |
| JPH10503771A (ja) | 1998-04-07 |
| AU685980B2 (en) | 1998-01-29 |
| BR9508521A (pt) | 1997-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5612377A (en) | Method of inhibiting leukotriene biosynthesis | |
| EP0196184B1 (en) | Aryl derivatives | |
| DE3875782T2 (de) | Leucotrien-antagonisten. | |
| US6121323A (en) | Bishydroxyureas | |
| EP0031954A2 (de) | Neue Sulfonamide, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| JPS58134070A (ja) | 置換尿素及びチオ尿素化合物 | |
| AT391694B (de) | Verfahren zur herstellung von neuen ethylendiaminmonoamid-derivaten | |
| EP0239907B1 (de) | Neue Phenoxyalkylcarbonsäure-Derivate, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende Arzneimittel | |
| PL154186B1 (en) | Method for manufacturing arylic derivatives of the hydroxamic acid | |
| US5110831A (en) | Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors | |
| JPS6033823B2 (ja) | サリチルアニリド誘導体及びその製造方法 | |
| DE69703437T2 (de) | 2-(3h)-oxazolone-derivate und ihre verwendung als cox-2 inhibitoren | |
| SU664561A3 (ru) | Способ получени производных 2-/4(ациламиноалкил)-фенокси/-алкилкарбоновой кислоты или их солей | |
| KR20030024710A (ko) | 항경련성 약물로서의 치환된 프탈리드 | |
| US4350685A (en) | Antiallergic imidodisulfamides | |
| NO315786B1 (no) | Inhibisjon av leukotrienbiosyntese med ureaderivater | |
| DE2737738A1 (de) | Derivate der 3-minothiophen-4-carbonsaeure, herstellungsverfahren und mittel cyclische verbindungen | |
| DE19803003A1 (de) | 5-Aroylnaphthalinderivate | |
| IL44570A (en) | Pyridinecarboxamide sulfonylurea derivatives and their preparation | |
| AT390948B (de) | Verfahren zur herstellung von neuen benzamid-derivaten | |
| FR2624856A1 (en) | Tromethamine salt of 1-methyl-ss-oxo- alpha -(phenylcarbamoyl)-2-pyrrolepropionitrile | |
| US5658952A (en) | 1-[4-(4'-sulfanilyl)phenyl]urea and derivatives for the treatment of Leishmaniasis | |
| EP0128021B1 (en) | Tetrahydro-beta-carboline derivatives and process for the preparation thereof | |
| MXPA97000860A (en) | Inhibition of the biosynthesis of leukotrians with u derivatives | |
| US3944524A (en) | 4-Substituted-1-piperidinesulfonamides |